» Articles » PMID: 32162188

Home Medicines Reviews and Residential Medication Management Reviews in Western Australia

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2020 Mar 13
PMID 32162188
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background Australian government funding for Residential Medication Management Reviews and Home Medicines Reviews commenced in 1997 and 2001 respectively. Limited data are available on their provision in Australia. Objective To investigate the extent and characteristics of Home Medicines Review and Residential Medication Management Review services provided by accredited pharmacists practising in Western Australia. Setting Pharmacists in Western Australia accredited by the Australian Association of Consultant Pharmacy or Society of Hospital Pharmacists of Australia. Method A paper questionnaire was developed and sent to 198 accredited pharmacists in Western Australia in June 2017. Simple descriptive statistics summarised demographic information and other responses. Logistic regression evaluated factors associated with the frequency of provision of Home Medicines Reviews. Main outcome measure Frequency and factors influencing services provided. Results Of 102 (51.5%) questionnaires returned, 67 (65.7%) respondents were female. Many were aged between 31 and 40 years (53; 52.0%). Most were accredited by the Australian Association of Consultant Pharmacy (101; 99.0%) and mainly offered Home Medicines Reviews (70; 68.6%). Home Medicines Reviews provided over the previous 12 months were limited in frequency with one quarter providing either 1-10 (27; 26.5%) or 21-50 (28; 27.5%) reviews. The median "average" preparation, interview and report writing times, plus communication with other health professionals aggregated to 175.0 min (interquartile range: 140.0-235.0 min) for Home Medicine Reviews and 110.0 min (90.0-140.0) for Residential Medication Management Reviews. Pharmacists born overseas and those who were accredited for a longer time were associated with performing 51 or more Home Medicines Reviews annually. Only one-third (36/101; 35.6%) agreed the current payment was appropriate. Most agreed their Home Medicines Reviews (92/96; 95.8%) and Residential Medication Management Reviews (26/28; 92.9%) provided improved patient outcomes. Over 97% of accredited pharmacists intended to continue to remain accredited. Conclusions Wide variations were evident in the times taken for tasks associated with performing reviews. Most respondents considered their medication reviews contributed to improved patient outcomes. The wide variation in times taken for the reviews suggests a tiered structure for service provision, with appropriate payment within each tier, since most consider current remuneration inadequate.

Citing Articles

Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.

Vidonscky Luthold R, Cateau D, Jenkinson S, Streit S, Jungo K BMC Health Serv Res. 2024; 24(1):849.

PMID: 39061037 PMC: 11282592. DOI: 10.1186/s12913-024-11339-8.


Pharmacist-led medication management services: a qualitative exploration of transition-of-care cardiovascular disease patient experiences.

Bennetts J, White J, Croft H, Cooper J, McIvor D, Eadie N BMJ Open. 2024; 14(5):e082228.

PMID: 38777587 PMC: 11116877. DOI: 10.1136/bmjopen-2023-082228.


Feasibility of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults.

Hikaka J, Hughes C, Jones R, Amende H, Connolly M, Martini N Explor Res Clin Soc Pharm. 2022; 2:100018.

PMID: 35481129 PMC: 9031728. DOI: 10.1016/j.rcsop.2021.100018.


National Trends and Policy Impacts on Provision of Home Medicines Reviews and Residential Medication Management Reviews in Older Australians, 2009-2019.

Sluggett J, Collier L, Bartholomaeus J, Inacio M, Wesselingh S, Caughey G Int J Environ Res Public Health. 2021; 18(18).

PMID: 34574821 PMC: 8467825. DOI: 10.3390/ijerph18189898.


Home medicines reviews: a national survey of Australian accredited pharmacists' health service time investment.

Patounas M, Lau E, Chan V, Rigby D, Kyle G, Khatri J Pharm Pract (Granada). 2021; 19(3):2376.

PMID: 34457093 PMC: 8370188. DOI: 10.18549/PharmPract.2021.3.2376.

References
1.
de Oliveira Santos Silva R, Macedo L, Dos Santos Junior G, Aguiar P, de Lyra Junior D . Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews. PLoS One. 2019; 14(1):e0210312. PMC: 6328162. DOI: 10.1371/journal.pone.0210312. View

2.
Mossialos E, Courtin E, Naci H, Benrimoj S, Bouvy M, Farris K . From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management. Health Policy. 2015; 119(5):628-39. DOI: 10.1016/j.healthpol.2015.02.007. View

3.
Zermansky A, Petty D, Raynor D, Freemantle N, Vail A, Lowe C . Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001; 323(7325):1340-3. PMC: 60673. DOI: 10.1136/bmj.323.7325.1340. View

4.
Lenander C, Elfsson B, Danielsson B, Midlov P, Hasselstrom J . Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014; 32(4):180-6. PMC: 4278387. DOI: 10.3109/02813432.2014.972062. View

5.
Kogut S, Goldstein E, Charbonneau C, Jackson A, Patry G . Improving medication management after a hospitalization with pharmacist home visits and electronic personal health records: an observational study. Drug Healthc Patient Saf. 2014; 6:1-6. PMC: 3900312. DOI: 10.2147/DHPS.S56574. View